Sumitomo Pharma Co., Ltd.
Rethymic
Allogeneic processed thymus tissue–agdc.
Approved to treat: Congenital athymia.
Report side effects/adverse reactions at 833-369-9868.
Rethymic
Allogeneic processed thymus tissue–agdc.
Approved to treat: Congenital athymia.
Report side effects/adverse reactions at 833-369-9868.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.